Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses

Figure 2

Time-plasma concentration profile of TP300, TP3076 and TP3011. A: The plasma concentration profile of TP300. B: The plasma concentration profile of TP3076. C:The plasma concentration profile of TP3076. Square:1 mg/m2, Circle:2 mg/m2, Triangle (point up):4 mg/m2, Cross:6 mg/m2, X:8 mg/m2, Diamond:10 mg/m2, Triangle (point down):12 mg/m2.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us